PTC Therapeutics Continue To Fight For Duchenne Muscular Dystrophy Community
Even after the third denial from the U.S. FDA, Food and Drug Administration, PTC Therapeutics Incorporation will not stop fighting for the drug Translarna that they believe will help patients…